GlassScriptPhysician profile
Rekha D Alexander
NPI 1841496262
$602.27
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.44 · 2020: $64.96 · 2022: $53.29 · 2023: $270 · 2024: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $94.99 | 2023-2024 | Dalvance, Avycaz |
| Gilead Sciences, INC. | $86.08 | 2023-2024 | Veklury |
| Merck Sharp & Dohme LLC | $74.30 | 2022-2023 | Verquvo, Dificid, Zerbaxa |
| Janssen Pharmaceuticals, INC | $72.33 | 2019-2024 | Xarelto |
| Pfizer INC. | $70.65 | 2023 | |
| Portola Pharmaceuticals, LLC | $57.24 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.82 | 2019 | |
| Ucb, INC. | $25.36 | 2020 | |
| Xeris Pharmaceuticals, INC. | $23.98 | 2024 | Gvoke Hypopen |
| Aurinia Pharma U.S., INC. | $21.01 | 2023 | Lupkynis |
| Alexion Pharmaceuticals, INC. | $18.88 | 2022 | |
| Vifor Pharma, INC. | $15.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rekha Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.